Riverain Technologies develops medical software intended to improve the detection, characterization, and management of lung cancers and other lung diseases. The company's software leverages patented image normalization and suppression technology to achieve robust solutions that generalize across different manufacturers devices and imaging protocols. The patented suppression technology improves the detection of lung diseases and other clinical conditions via bone-suppressed X-ray images and vessel-suppressed CT series that remove challenging structures, making disease more visible and easier to identify.